Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SCHD vs GSK✓SelectedUSD · GSKSCHD vs GSK performance historyLatest closeAs of-1.44%11/19
Stock and ETF performance explorer

SCHD vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+560.3%
GSK return
+130.1%
Excess return
+430.3%
Maximum drawdown
-33.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.4%-1.6%+0.1%-0.9%
7D-4.8%-4.7%-0.1%-3.2%
30D-1.4%-4.7%+3.3%+0.2%
3M-1.8%-8.8%+7.0%+1.2%
6M+8.2%-4.6%+12.9%+9.5%
YTD+27.7%+1.0%+26.8%+25.8%
1Y+31.5%+6.9%+24.6%+26.8%
3Y+60.9%+52.5%+8.4%+31.8%
5Y+56.9%+40.3%+16.6%+30.4%
10Y+237.8%+99.0%+138.9%+136.9%
All+560.3%+130.1%+430.3%+310.2%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling